Givot Yahash: The Contracts Are Signed, but Funding and Execution Still Decide Everything
Givot now has a signed operating plan for Meged 6 and Meged 5 at a much lower direct cost than the old scenario, but it still has no revenue, almost no cash, and the path to operations runs through capital raises, bridge loans, and a fight over who controls the financing spigot. 2026 looks like a proof year financed by stopgaps, not a breakout year.
Company Overview
From a distance, Givot Yahash can look like a small oil exploration partnership with a familiar geological story. That is too shallow a read. As of the end of 2025, this is no longer a partnership selling oil. It is a platform trying to prove that the Meged field can still be turned from a geological option into a cash-generating asset. The core driver is not the reserve report on paper. It is the ability to execute the Meged 6 operation, then Meged 5, before funding stress, debt and governance friction consume what little room is left.
What is actually working now? After years of delays, the partnership reached signed agreements in early March 2026 with H2OIL and ANTECH for the sidetrack operations, and it positioned Ken Stanley as the de facto operations and drilling manager. That matters. The partnership itself says the new operating structure cuts direct activity cost to about $10 million, versus an earlier Schlumberger proposal of $15.7 million to $17.8 million and a later Schlumberger price indication of roughly $27 million to $32 million.
What is still not clean? There has been no oil revenue for five straight years, year-end cash was only $105 thousand, the working-capital deficit stood at $28.8 million, and total scheduled obligations reached $39.9 million. So the Givot story in 2026 is not only about whether oil exists. It is about whether financing, approvals and execution can line up long enough to get the operation to the starting line.
A superficial reader may get stuck on two things: the 2P and 3P reserve numbers, and the fact that the operating contracts are finally signed. But the reserve report shows 1P of zero, which means there is still no proved reserve base that directly bridges into common-unit economics. And the signed contracts do not change the fact that the partnership still says it needs about $9 million to $10 million of additional financing for the immediate plan, after already using funds that had been placed in trust.
There is also a practical actionability constraint. On the latest trading day in the market snapshot, the participation unit traded only about NIS 37 thousand of daily turnover while market value was around NIS 93.6 million. Even if the thesis improves, this remains a thinly traded name that will struggle to absorb dilution, control changes or sharp execution updates smoothly.
The Economic Map
| Axis | Current position | Why it matters |
|---|---|---|
| Ongoing business | No production and no revenue in 2021 through 2025 | Without oil cash flow, every step is funded by raises and loans |
| Core asset | 95.282% interest in the Rosh HaAyin I/11 lease through April 1, 2032 | Almost all value rests on one lease and on Meged 5, 6 and 8 |
| Geological proof | 1P is zero, 2P is about 2.514 million barrels, 3P about 10.353 million barrels | There is geological optionality, but not yet a proved value layer accessible to unit holders |
| Active bottleneck | Financing the operation, controlling issuance decisions, and proving stable production | This is the thesis core, not just geology |
| Control structure | The partnership operates through a general partner, trustee and supervisor, with conflict around issuance authority | In Givot, the capital faucet is a governance issue as much as a financial one |
That chart is an important reminder: the partnership did produce in the past, and Meged 5 delivered roughly 1.247 million barrels cumulatively. But production stopped in June 2020, and since then the geological story has not translated into revenue. Anyone reading Givot as an active producer is simply reading the company incorrectly.
Events And Triggers
The Operating Trigger
The first trigger: in March 2026 the partnership signed agreements with H2OIL and ANTECH, and it plans to bring equipment and crews near the end of the second quarter of 2026 in order to begin work at the start of the third quarter. This is the most important change in the current cycle. For years, Givot talked about planning, experts and progress. Now there is an execution framework, milestones and payment terms.
But it is not a clean trigger. Direct operating cost is estimated at about $10 million, yet the partnership also adds site-preparation, equipment and ongoing-expense needs of about $3.2 million, overdue obligations of about $1.8 million, and a contingency budget of roughly $3 million. So even if the contracts themselves look cheaper than before, the broader economic envelope is still heavy.
The second trigger: management presents a timetable with Meged 6 in the second quarter and Meged 5 in the third quarter, followed by another well next year. That is ambitious. The partnership also makes clear that these assumptions depend on financing, on avoiding technical delays, and on execution without unexpected setbacks. This is no longer a theoretical delay story. Every link, from prepayments to crew arrival, can still delay the entire chain.
The Financing Trigger
The third trigger: in February 2026 the partnership reported receipt of the remaining NIS 1 million from an enlarged loan facility, after already drawing NIS 1.5 million in late December 2025. Even after year-end, the partnership was still living from one bridge draw to the next rather than from operating cash flow.
The fourth trigger: at the meeting called for February 4, 2026, unit holders were asked to instruct the trustee and supervisor to extend another NIS 1.3 million loan, without interest and without collateral, to be repaid from the first issuance that would be completed. That is not a small detail. It says plainly that the partnership is no longer financing the path to operations from the market alone. It still needs bridge funding just to reach the next financing event.
The Governance Trigger
The fifth trigger: in January 2026 the partnership brought two contradictory proposals to unit holders regarding control over issuance structure and issuance timing. One proposal would move those decisions to the board. The second would require prior written approval from the external director, Moshe Polet, and the supervisor, Agadi Torati, before board decisions could take effect. That shows the fight at Givot is not only about how much money must be raised. It is also about who controls the raise process.
The sixth trigger: effective February 25, 2026, Dmitri Dubovis was appointed as a regular director. The appointment filing says he holds about 4.09 million units, around 1.33% of the participation units, and also acts under power of attorney for Zhanna Tomashevskaya, described as an interested party holding about 15% of the participation units. That is a clear sign that board composition itself reflects an influence struggle around capital allocation and control.
The market will want to read Givot through the drilling story, but in the near term the filing says something else: financing already dominates operations, so even a positive operating trigger still has to travel through debt, bridge funding and dilution before it becomes clean economic improvement.
Efficiency, Profitability And Competition
This Is No Longer A Margin Story
At Givot there is currently no normal competitive story of price, volume and mix. There is no revenue. So profitability analysis does not start from gross margin. It starts from the question of how much of the loss reflects carrying the platform and how much reflects the price of time.
Operating loss in 2025 was $1.733 million, versus $1.911 million in 2024. That is some improvement, but it is secondary. Oil and gas exploration expense rose slightly to $1.336 million, and general and administrative expense rose to $726 thousand. Even without production, Givot still has to pay for security, insurance, licenses, professional services and overhead.
The real gap sits below the operating line. Finance expense jumped to $8.168 million, versus $4.170 million in 2024. Of that, $4.265 million was loan interest and $3.361 million came from foreign-exchange movements. Finance income was just $145 thousand. Net finance expense therefore reached $8.023 million, more than 4.6 times operating loss. Put simply, Givot lost money mainly because it is leveraged and living on debt, not because the ongoing platform suddenly became much more expensive to run.
Where Value Gets Stuck Between 2P And 1P
This is one of the most important points in the report. The reserve report as of December 31, 2025 shows 1P of zero, 2P of about 2.514 million barrels and 3P of about 10.353 million barrels. So yes, the partnership can argue there is geological optionality. It cannot yet argue there is a proved, accessible value layer already supporting the current capital structure.
That is the heart of the story. Anyone reading only the 2P and 3P figures may think the problem is merely patience. In reality the problem is the proof chain. Meged 6 needs to deliver a convincing test, then Meged 5 needs to reopen lower intervals, and only then can the partnership seriously talk about a field development plan and stable commercial production.
What Meged 5 History Really Says
Meged 5 is both the source of hope and the source of warning. It produced in the past, but the report reminds readers that during 2019 production rate deteriorated sharply, and in June 2020 the well was shut. Management advisers concluded that it no longer made practical or economic sense to keep trying to produce from layer b8, so the new idea is to seal that layer and test lower intervals.
That means even inside Meged 5, this is not a simple return to what used to work. It is an attempt to rebuild the thesis around different zones after the layer that once proved production had already run down.
That chart makes clear why pure operating-efficiency talk misses the point. Even in 2025, financing cash flow almost did nothing more than offset the operating cash burn. Without loans, offerings and refinancing, the partnership would not have finished the year with even $105 thousand of cash.
Cash Flow, Debt And Capital Structure
The Real Cash Picture
For Givot, the right framing is all-in cash flexibility. This is not a business with a stable operating base that can be isolated from growth spending. It is a partnership living from bridge to bridge. On that basis, the picture is severe: the year ended with only $105 thousand of cash after $2.396 million of cash used in operations, $347 thousand of interest paid, and only $2.452 million of financing inflow.
Even in the cash-flow reconciliation, the negative operating cash flow does not come from a collapse in revenue because there is no revenue. It comes from a $9.756 million annual loss, much of it financing-related, together with a $1.754 million increase in payables and other accruals. In plain terms, Givot is not producing cash. It is deferring, rolling and financing its way toward the next attempt.
Debt Already Sits On Future Revenue
Liabilities at the end of 2025 stood at $38.066 million. Of that, $29.241 million were current. Related-party loans were $22.964 million, and interest payable on those loans was another $4.1 million. Loans from others were $1.582 million, while suppliers and service providers were $6.174 million.
But the structure matters more than the headline amount. In its liquidity-risk table, the partnership shows scheduled obligations of $39.917 million: $3.763 million inside three months, $25.692 million within a year, $3.485 million between one and three years, and $6.977 million between three and five years. Set that against $105 thousand of cash and the question is not whether there is liquidity pressure. The question is only how, or whether, it will be resolved.
The Neot Dekalim Loan Is More Than A Footnote
One of the most important loan disclosures is the NIS 20 million loan from Neot Dekalim. The filing explicitly says the partnership is not in compliance with its financial covenants, including a minimum adjusted equity threshold of $6 million and a minimum sales-coverage ratio of 1.3. Neot Dekalim had not accelerated the loan by the filing date, but the fact that the covenants are breached shows that Givot's financing flexibility depends on lender patience, not on internal balance-sheet strength.
To secure those obligations, the partnership pledged, among other things, rights to future Meged 5 and Meged 6 revenue, dedicated bank accounts, and rights connected to oil sales. The filing also says there was no cash in the reserve account as of the report date. That matters. Part of the future upside, if and when it returns, is already earmarked for debt service.
Dilution Is Not A Side Effect. It Is The Funding Model
During 2025, the partnership issued 25.93 million new participation units through offerings and warrant exercises, and by the report date it had 308.36 million units outstanding. In the later market snapshot, the issued amount had already reached 316.06 million units. At Givot, fresh equity is not an optional growth tool. It is a recurring substitute for missing cash flow.
That chart shows why the deposit line is not a comfort item. The $2.558 million of long-term deposits are pledged to banks as execution guarantees. It is an asset on the balance sheet, but it does not really create room for common-unit holders.
Outlook And Forward View
Before getting into the detail, four non-obvious findings frame 2026 correctly:
- Financing is still the main event. The Meged 6 and Meged 5 operating contracts are signed, but the partnership itself still says it needs about $9 million to $10 million of additional financing.
- A cheaper plan does not solve the capital structure. Direct operating cost came down versus the old proposals, but the surrounding cash needs remain heavy, including site preparation, overdue obligations and a contingency line.
- The problem is no longer only managerial. It is also governance-related. The fight over issuance authority and the inability to fund even a CEO search show that the organizational bottleneck is inseparable from the financing bottleneck.
- Proof for unit holders still has to come through Meged 6. Without a convincing production test, 2P and 3P remain option numbers more than economic proof.
This Is A Proof Year Financed By Stopgaps
If 2026 needs a label, it is not a breakout year. It is a proof year financed by stopgaps. The partnership is trying to move from an entity living on interim funding to one that can restart a real producing asset. That transition is possible, but it has to clear three hard checkpoints: secure financing, execute Meged 6, then translate that result into Meged 5 and a field development plan.
That means the market will not judge Givot by reserve tables alone. It will judge the company by a visible chain of events: prepayments, equipment arrival, work commencement, test results, and the ability to show that the next financing step is being raised on progress rather than on dilution alone.
What Must Happen At Meged 6
For management, Meged 6 is the well that has to restore confidence in execution. The report describes a specific plan: continue from the window already drilled, run a sidetrack at a 35-degree angle from roughly 4,250 meters, then move the equipment to Meged 5. The same report also reminds readers that the earlier attempt showed the method could work, but drilling was slow, wellbore stability deteriorated, and the drill bit broke and remained in the well.
So there is both a positive anchor and a harsh technical reminder here. The task in 2026 is not merely to drill. It is to show that the partnership can run a controlled, stable sidetrack and intersect commercially relevant natural fractures. If that happens, the story changes. If not, the concern that Givot is funding another expensive experiment will harden.
Where Meged 5 Fits In
Meged 5 is not a backup plan. It is the next step inside the same thesis. The partnership says it intends to seal layer b8 and examine lower intervals, including through sidetracks, after work at Meged 6. So even if Meged 6 works, this is not a simple return to former production. It is an attempt to reopen value through different intervals.
What The Market Is Likely To Watch
In the coming days and weeks, the market will focus first on funding, not on geology. It will want actual capital: prepayments made, a financing closed, or a bridge facility secured.
Over the following quarter or two, the market will watch for execution markers: equipment arrival, operations actually starting on schedule, and no renewed blockage from regulation, insurance, staffing or funding.
Over the next two to four quarters, the market will want a stable Meged 6 flow profile, an orderly move to Meged 5, and a field development plan filed within six months of Meged 6 testing, as the partnership itself states.
That chart matters because it prevents an easy reading of the report. The second half was slightly less bad than the first, but not enough to change the thesis. Any real change now has to come from 2026 execution, not from small 2025 reporting differences.
Risks
The first risk is existential. The auditor explicitly highlights substantial doubt about the partnership's ability to continue as a going concern. That is not boilerplate. It sits on top of a $198.3 million accumulated loss, a $28.8 million working-capital deficit and a $32.5 million equity deficit.
The second risk is funding and dilution. The partnership is already relying on bridge loans, funds placed in trust, and repeated equity issuance. Even if operations do start, the next funding round may not arrive on attractive terms.
The third risk is execution. Meged 6 requires technically complex work, and Meged 5 requires more than just reopening an existing producer. The report itself recalls earlier operational problems, depleted intervals and dependence on outside crews, equipment and timing.
The fourth risk is regulatory. Lease terms, planning friction and the TATAL 100 planning process all show that Givot's rights do not operate in a vacuum.
The fifth risk is governance. The partnership works through a general partner, trustee and supervisor, and the issuance authority question has already become a conflict point. In that structure, even economically sensible decisions can still stall if there is no agreement on who gets to authorize them.
The sixth risk is market microstructure. The report already shows liquidity risk in the financial sense, and the market snapshot adds a trading-liquidity problem as well. A name that trades so lightly is highly sensitive to dilution, control shifts and sharp interpretations of each financing or operational update.
Conclusion
Givot's 2025 report does not describe an oil producer returning to normal operations. It describes a partnership trying to buy itself one more proof path. What supports the thesis is that this time there are signed operating agreements, a clearer execution framework and a direct operating cost far below the prior scenario. What blocks the thesis is the same thing that has blocked Givot for years: no cash flow, heavy debt, and a path to each next step that runs through capital raises, bridge funding and governance friction.
In the near and medium term, market reaction will not be set by reserve tables. It will be set by three simpler tests: does the money arrive, does the equipment arrive, and does Meged 6 provide a production proof point strong enough to support Meged 5 and a field development plan.
| Metric | Score | Explanation |
|---|---|---|
| Overall moat strength | 2 / 5 | There is an existing oil asset, accumulated field knowledge and an updated operating plan, but there is still no cash flow, no 1P, and all value depends on future proof |
| Overall risk level | 5 / 5 | Going-concern pressure, deep deficits, heavy debt, immediate funding needs and high execution risk |
| Value-chain resilience | Low | The model depends on service providers, financing, approvals and imported execution capacity, with no internal cash buffer |
| Strategic clarity | Medium | The timeline and operating steps are clearer than before, but execution still depends on financing and governance resolution |
| Short-seller positioning | 0% of float, no meaningful signal | Short data are negligible and do not provide a material confirmation or contradiction here |
Current thesis in one line: Givot has moved from an unsigned operating concept to a signed but still unfunded execution plan, so equity value still depends first on financing and execution, and only then on geology.
What changed versus the prior read: this cycle now includes a clearer operating framework, Ken Stanley as the central execution figure, and contracts signed at a cost far below the earlier scenario. But the fight over issuance control and the continued use of bridge loans show that the financing bottleneck is even more visible than before.
The strongest counter-thesis: if Meged 6 delivers stable flow and financing closes without a severe control shock, the market may be overstating the weight of the going-concern and debt issues while understating the optional value embedded in 2P and 3P.
What could change market interpretation in the near to medium term: a real financing close for the operation, actual work starting on time, and an initial sign that Meged 6 can deliver repeatable flow rather than a one-off technical event.
Why this matters: the company is a clean test of whether a resource partnership with a weak balance sheet and complex governance can turn geological optionality into economically accessible value.
What must happen over the next two to four quarters for the thesis to strengthen is straightforward: financing has to close, Meged 6 operations have to start, the technical result has to be credible, and the move into Meged 5 has to follow in an orderly way. What would weaken the read is another delay, a failed financing, another technical setback, or a deeper fight over who controls the capital faucet.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.
At Givot, the board has held the formal handle over issuance structure and timing since late January 2026, but practical control over the capital faucet remains multi-layered because the supervisor stays embedded in the trustee architecture and operating oversight, while the boa…
Meged 6 is not a test of whether oil exists in Meged Field. It is a test of whether contingent resources can start moving into developable reserves.
At Givot, unit holders sit behind pledged deposits, secured claims, covenant-breached related-party debt, bridge funding, and ordinary liabilities, so the next cash is needed to stabilize the structure before it becomes accessible value for them.